Welcome to our dedicated page for ATI Physical Therapy news (Ticker: $ATIP), a resource for investors and traders seeking the latest updates and insights on ATI Physical Therapy stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ATI Physical Therapy's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ATI Physical Therapy's position in the market.
ATI Physical Therapy reported strong financial results for the first quarter of 2024, with net revenue of $181.5 million, an 8.7% increase from the first quarter of 2023. The company saw growth in patient visits and revenue, driven by operational excellence and capacity expansion. Adjusted EBITDA increased by 34.9% to $6.5 million. Despite a net loss, ATI remains optimistic about continued growth in 2024.
Tom Denninger appointed as Executive Director of the Institute for Musculoskeletal Advancement (iMSKA). Founded by ATI Physical Therapy, iMSKA aims to drive musculoskeletal research and post-secondary education. Mr. Denninger will lead the Institute in equipping, training, and transforming MSK care delivery through research and post professional development. iMSKA also announces an Advisory Board comprised of industry leaders. Applications for research fellowships and specialized programs will be available soon.